provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content
Reblozyl Coupon - Reblozyl 75mg vial

Reblozyl

luspatercept
Used for Anemia
Used for Anemia

Reblozyl (luspatercept or luspatercept-aamt) is an injectable medication used to treat anemia (low red blood cells) in adults with beta thalassemia or certain myelodysplastic syndromes (MDS) who require regular red blood cell transfusions. Reblozyl (luspatercept) is given by a healthcare provider every 3 weeks.

Last reviewed on May 5, 2022
basics-icon

What is Reblozyl (luspatercept)?

What is Reblozyl (luspatercept) used for?

How Reblozyl (luspatercept) works

Reblozyl (luspatercept) is a biologic called an erythroid maturation agent. It helps immature red blood cells develop and work properly. By raising the amount of healthy red blood cells, Reblozyl (luspatercept) can treat your anemia.

Drug Facts

Common BrandsReblozyl
Drug ClassBiologic
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityPrescription only
basics-icon

What are the side effects of Reblozyl (luspatercept)?

The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.

Common Side Effects

  • Tiredness (14-41%)
  • Headache (14-26%)
  • Muscle or bone pain (20%)
  • Joint pain (19%)
  • Dizziness (11-18%)
  • Nausea (9-16%)
  • Diarrhea (12-16%)
  • Cough (14%)
  • Stomach pain (14%)
  • Difficulty breathing (13%)
  • Allergic reaction (10%)

Other Side Effects

  • Flu-like symptoms
  • Upper respiratory infection
  • High blood pressure
  • Fast heart rate
  • Liver problems
  • Injection site reaction
  • Feeling faint

Serious Side Effects

Contact your healthcare provider immediately if you experience any of the following.
  • Blood clots: chest pain, trouble breathing, shortness of breath, pain in leg, cold or pale arm or leg, sudden numbness or weakness on one side of the body, severe headache or confusion, trouble speaking, difficulty walking, dizziness

Source: DailyMed

The following side effects have also been reported

Side effects that you should report to your care team as soon as possible:

  • Allergic reactions—skin rash, itching, hives, swelling of the face, lips, tongue, or throat
  • Blood clot—pain, swelling, or warmth in the leg, shortness of breath, chest pain
  • Increase in blood pressure
  • Severe back pain, numbness or weakness of the hands, arms, legs, or feet, loss of coordination, loss of bowel or bladder control

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

pros-and-cons

Pros and cons of Reblozyl (luspatercept)

thumbs-up

Pros

Treatment is every 3 weeks

Can lower the need for RBC transfusions

Dose is individualized for each person

thumbs-down

Cons

Not approved for children

Has to be given by injection

Can't give yourself the injection; must be given by a provider

pharmacist-tips

Pharmacist tips for Reblozyl (luspatercept)

pharmacist
  • You will get regular blood tests throughout your treatment with Reblozyl (luspatercept). Your provider will monitor your hemoglobin to see if your anemia is getting better.

    • Remember to go to all of your treatment appointments to make sure you get your injections on time.

      • It's also important to get all of your labs done so your provider can adjust your dose properly.

        • Let your provider know if you're pregnant or planning to become pregnant before starting Reblozyl (luspatercept). Since this medication can cause harm to your unborn baby, speak with your provider for a safer medication.

          • If you're a female who's able to have a baby, your provider will have you take a pregnancy test before starting Reblozyl (luspatercept). Take birth control during treatment and for 3 months after the last dose to prevent pregnancy.

            • It's possible for Reblozyl (luspatercept) to pass into your breast milk and cause harm to your baby. Don't breastfeed during your treatment and for 3 months after the last dose.

              • Reblozyl (luspatercept) might make it harder to become pregnant if you're a female, so let your provider know if this is a concern for you.

                faqs

                Frequently asked questions about Reblozyl (luspatercept)

                Why is Reblozyl (luspatercept) only for anemia caused by certain blood conditions?
                Reblozyl (luspatercept) is approved for people with beta thalassemia or certain types of myelodysplastic syndromes (MDS). In both of these conditions, red blood cells don't form properly and can lead to anemia. Beta thalassemia is a genetic condition where red blood cells don't form correctly and can't carry oxygen your body needs because of misformed hemoglobin (protein in red blood cells that carries oxygen). Myelodysplastic syndromes (MDS) are conditions that cause the bone marrow to make red blood cells that don't develop correctly. Reblozyl (luspatercept) helps the maturing process of red blood cells so they can develop properly.
                Can Reblozyl (luspatercept) replace my red blood cell (RBC) transfusions?
                No. Reblozyl (luspatercept) can lessen the need for or amount of RBC transfusions if your body responds to the treatment. But it can't be used as a substitute for the transfusions. This medication takes time to work, so you would still need to get RBC transfusions if you need to treat your anemia right away.
                Where will Reblozyl (luspatercept) be injected?
                Reblozyl (luspatercept) can be injected subcutaneously (under the skin) into the upper arm, thigh, or stomach.
                How well does Reblozyl (luspatercept) work?
                Studies have shown that 1 in 5 people with beta thalassemia lowered their requirement for RBC transfusion by about 30% over 12 weeks of Reblozyl (luspatercept) treatment. For those with MDS, about 4 in 10 people receiving Reblozyl (luspatercept) didn't need RBC transfusions for at least 8 weeks in the first 24 weeks of treatment.
                How long is the treatment with Reblozyl (luspatercept)?
                Your provider will determine how long your treatment should be based on how you respond to Reblozyl (luspatercept) injections. Your provider will also adjust your dose according to your hemoglobin levels, current symptoms, side effects, and your need for RBC transfusions. Depending on your anemia and symptoms, speak with your provider to see how long you will need to receive Reblozyl (luspatercept) injections.
                GoodRxEducationalIcon

                How to save using GoodRx

                Compare Prices
                1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
                Select your free coupon
                2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
                Show coupon to your pharmacist
                3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
                Get free couponLearn more
                warings-icon

                What are the risks and warnings for Reblozyl (luspatercept)?

                Reblozyl (luspatercept) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.

                risk-warning

                Blood clots

                • Risk factors: Spleen removal | Taking hormone replacement therapy | Taking birth control | Smoking

                  Some people with beta thalassemia have experienced a blood clot while taking Reblozyl (luspatercept). Speak with your provider before starting this medication if you have a history of blood clots or have any of the risk factors listed above. Your provider can give you medications to lower your risk of blood clots, or find a different medication that's safer for you. Get medical help right away if you experience signs of a blood clot, such as chest pain, leg pain, trouble breathing, sudden numbness or weakness on one side of the body, severe headache or confusion, or trouble speaking or walking.

                  risk-warning

                  High blood pressure

                  Reblozyl (luspatercept) can raise your blood pressure. There's a risk of developing high blood pressure or a worsening of your condition if you currently have high blood pressure. Discuss with your provider to see if you need blood pressure medications or if you need adjustments to your current medications.

                  risk-warning

                  Harm to unborn baby

                  Reblozyl (luspatercept) might cause harm to your unborn baby if you're getting this medication during pregnancy. If you're a female who can have a baby, use an effective form of birth control during your treatment with Reblozyl (luspatercept) and for at least 3 months after the last dose. Let your provider know right away if you become pregnant or think that you might be pregnant during your treatment.

                  dosage

                  Reblozyl (luspatercept) dosage forms

                  Typical dosing for Reblozyl (luspatercept)

                  You provider will determine your dose based on your body weight. The typical starting dose is 1 mg/kg of body weight injected subcutaneously (under the skin) once every 3 weeks. Your provider will adjust your dose based on your response to the medication. Injections are given by your healthcare provider.

                  images

                  Reblozyl (luspatercept) images

                  white - Reblozyl 75mg Powder for Injection
                  This medicine is White Vial.white - Reblozyl 75mg Powder for Injection

                  Get savings updates for Reblozyl (luspatercept)

                  Receive price alerts, news, and other messages from GoodRx about Reblozyl (luspatercept) and other healthcare topics and relevant savings offers.

                  By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

                  Browse medications

                  View All

                  Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.